English | Español
Patient Daily | Feb 5, 2026

Sandbox approach proposed as new model for rare disease drug development
Patient Daily | Feb 5, 2026

Revolution Medicines remains independent after failed takeover talks with Merck
Patient Daily | Feb 5, 2026

Study finds tertiary treatment reduces antibiotic resistance transfer from reclaimed irrigation water
Patient Daily | Feb 5, 2026

Review highlights possible link between microplastics exposure and Parkinson’s disease mechanisms
Patient Daily | Feb 5, 2026

Canadian study finds no adverse effects from daily full-fat dairy consumption in overweight adults
Patient Daily | Feb 5, 2026

Study links high-iron environments to persistent but less damaging Pseudomonas lung infections
Patient Daily | Feb 5, 2026

Editorial discusses promise of GLP‑1 drugs for reducing deaths among people with serious mental illness
Patient Daily | Feb 5, 2026

Review finds links between gut microbiome changes and Alzheimer’s progression

Trending
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Lilly reports late-stage diabetes data for triple-G agonist retatrutide